A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US (clinicaltrials.gov) - Sep 30, 2026 - P=N/A | N=150 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Trial completion date: Dec 2025 ➔ Dec 2027
HEOR • Real-world evidence • Trial completion date • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|